A predictive model to assess the risk of developing hyperlipidemia in patients with type 2 diabetes.
<h4>Background</h4>Type 2 diabetes (T2D) is increasingly recognized as a significant global health challenge, with a rising prevalence of hyperlipidemia among diabetic patients. Effectively predicting and reducing the risk of hyperlipidemia in T2D patients to mitigate their cardiovascula...
Saved in:
| Main Authors: | Rujian Ye, Xitong Huang, Hehui Yang, Wei Pan, Ping Wang, Janhao Men, Dawei Huang, Shan Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0315781 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Type 1 diabetes mellitus, hyperlipidemia, and inflammatory bowel disease: a Mendelian randomization study
by: Xiangyin Liu, et al.
Published: (2024-01-01) -
EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01) -
Osteonecrosis of shoulder and femur in a patient with hyperlipidemia type FV
by: T V Kolesnik, et al.
Published: (2003-04-01) -
Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database
by: Qun Li, et al.
Published: (2025-02-01) -
Analysis of risk factors for hyperlipidemia in 1233 maintenance hemodialysis patients
by: LUO Deng-gui, et al.
Published: (2019-01-01)